@FierceBiotech: ICYMI from FierceCRO: PPD snags Acurian for recruitment software. News | Follow @FierceBiotech
@JohnCFierce: No Teva deal for Rexahn. Press release | Follow @JohnCFierce
@EmilyMFierce: This week's issue of FierceBiotech Research. Not subscribed? Sign up for free here. | Follow @EmilyMFierce
> The FDA is delaying their decision on Auxilium's bid to expand the use of Xiaflex to include Peyronie's disease. The new PDUFA deadline is Dec. 6. Report
> Pfizer ($PFE) is handing over a $1 million milestone payment to Oxford BioMedica as the antibody PF-06263507 enters the clinic. Report
> A group of scientists at Mount Sinai are setting up a biotech incubator in East Harlem. Report
@FierceMedDev: Sign up to receive our new publication FierceDiagnostics in your inbox each Wednesday. Sign up here | Follow @FierceMedDev
@DamianFierce: J&J is switching up its Chinese leadership as local authorities eye drug and device firms. News | Follow @DamianFierce
@MarkHFierce: The sleep apnea device industry is poised to get an infusion of a number of new treatments. ICYMI yesterday | Follow @MarkHFierce
> GlySure glucose monitor tests well in hospital trial. Item
> Study: Insulin pump beats injection in kids with Type 1 diabetes. Article
> InVivo tanks after pushing back spinal study. More
Pharma News
@FiercePharma: China arrests British consultant and wife for trafficking in private information. Pharma probe churns on… Yesterday's story | Follow @FiercePharma
@EricPFierce: Swiss CMO Siegfried building a manufacturing plant in China. ICYMI from FiercePharmaManufacturing | Follow @EricPFierce
@CarlyHFierce: ICYMI yesterday: Eye-drug specialist Akorn buys rival Hi-Tech for $640M. Article | Follow @CarlyHFierce
> Onyx staffers to get word on layoffs 30 days after Amgen deal wraps. Story
> Simcere going private thanks to $495M buyout by chairman. Report
> Endo's Qualitest unit snags niche generics player for $225M. News
> J&J rejigs Chinese ops to centralize under local chairman. Article
Drug Delivery News
@MichaelGFierce: Ceptaris nets first-ever FDA approval for topical lymphoma chemo gel. Article | Follow @MichaelGFierce
> Chip lined with human cells tests cancer drug delivery with minimal cost. Story
> Singapore team makes 'nanocages' for protein drug delivery. Article
> Lipidor, Karolinska post sound PhI/IIa results for novel spray-on psoriasis drug. News
> Nano-gold's penetrating methods revealed in MIT, Swedish study. More
> FDA clears Novo Nordisk's insulin injection pen for children. Item
Diagnostics News
> U Texas group finds ovarian cancer Dx works better over time. More
> Harvard, Danish team develop new brain cancer MRI approach. Story
> Applied Proteomics mulls Alzheimer's companion Dx. Article
> Life Technologies loses exec to Dx startup. Item
> Exosome, Mount Sinai forge Dx development partnership. Report
And Finally… A team at Johns Hopkins says that a specific protein, NY-ESO-1, is found in virtually all cases of high-grade meningiomas, a common brain tumor. And they say that this new target already figures in to a clinical study under way at the National Cancer Institute. Release